Status:
COMPLETED
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
Lead Sponsor:
Rock Creek Pharmaceuticals, Inc.
Conditions:
Smoking
Tobacco Use Disorder
Eligibility:
All Genders
23-72 years
Phase:
PHASE1
Brief Summary
A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire t...
Detailed Description
Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.
Eligibility Criteria
Inclusion
- Healthy adult smokers
- Smoking for at least 5 years
- Smoking at least one (1) pack of cigarettes a day
Exclusion
- Allergy to lozenge components
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01262170
Start Date
April 1 2010
End Date
April 1 2010
Last Update
October 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comfort Inn
Martinsburg, West Virginia, United States, 25401